Correction: The ribosomal RPL10 R98S mutation drives IRES-dependent BCL-2 translation in T-ALL.

Kampen, Kim R; Sulima, Sergey O; Verbelen, Benno; Girardi, Tiziana; Vereecke, Stijn; Fancello, Laura; Rinaldi, Gianmarco; Verbeeck, Jelle; Op de Beeck, Joyce; Uyttebroeck, Anne; Meijerink, Jules P P; Moorman, Anthony V; Harrison, Christine J; Spincemaille, Pieter; Cools, Jan; Cassiman, David; Fendt, Sarah-Maria; Vermeersch, Pieter; De Keersmaecker, Kim

Kampen, Kim R; Sulima, Sergey O; Verbelen, Benno; Girardi, Tiziana; Vereecke, Stijn; Fancello, Laura; Rinaldi, Gianmarco; Verbeeck, Jelle; Op de Beeck, Joyce; Uyttebroeck, Anne; Meijerink, Jules P P; Moorman, Anthony V; Harrison, Christine J; Spincemaille, Pieter; Cools, Jan; Cassiman, David; Fendt, Sarah-Maria; Vermeersch, Pieter; De Keersmaecker, Kim.

Afiliação

Kampen KR; Department of Oncology, Laboratory for Disease Mechanisms in Cancer, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium.
Sulima SO; Department of Oncology, Laboratory for Disease Mechanisms in Cancer, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium.
Verbelen B; Department of Oncology, Laboratory for Disease Mechanisms in Cancer, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium.
Girardi T; Department of Oncology, Laboratory for Disease Mechanisms in Cancer, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium.
Vereecke S; Department of Oncology, Laboratory for Disease Mechanisms in Cancer, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium.
Fancello L; Department of Oncology, Laboratory for Disease Mechanisms in Cancer, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium.
Rinaldi G; Laboratory of Cellular Metabolism and Metabolic Regulation, Center for Cancer Biology, VIB, Leuven, Belgium.
Verbeeck J; Department of Oncology, Laboratory of Cellular Metabolism and Metabolic Regulation, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium.
Op de Beeck J; Department of Oncology, Laboratory for Disease Mechanisms in Cancer, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium.
Uyttebroeck A; Department of Oncology, Laboratory for Disease Mechanisms in Cancer, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium.
Meijerink JPP; Department of Pediatric Oncology & Hematology, University Hospitals Leuven, Leuven, Belgium.
Moorman AV; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Harrison CJ; Leukaemia Research Cytogenetics Group, Northern Institute for Cancer Research, Newcastle University, Newcastle-upon-Tyne, UK.
Spincemaille P; Leukaemia Research Cytogenetics Group, Northern Institute for Cancer Research, Newcastle University, Newcastle-upon-Tyne, UK.
Cools J; Department of Gastroenterology-Hepatology and Metabolic Center, University Hospitals Leuven, Leuven, Belgium.
Cassiman D; Laboratory of Molecular Biology of Leukemia, Center for Human Genetics, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium.
Fendt SM; Laboratory of Molecular Biology of Leukemia, Center for Cancer Biology, VIB, Leuven, Belgium.
Vermeersch P; Department of Gastroenterology-Hepatology and Metabolic Center, University Hospitals Leuven, Leuven, Belgium.
De Keersmaecker K; Laboratory of Cellular Metabolism and Metabolic Regulation, Center for Cancer Biology, VIB, Leuven, Belgium.

Leukemia ; 33(4): 1055-1062, 2019 Apr.

Article em En | MEDLINE | ID: mdl-30850735

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Bélgica

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google